Caribou Biosciences, Inc. Quarterly Net Income (Loss) Attributable to Parent in USD from Q1 2020 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Caribou Biosciences, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q1 2020 to Q3 2024.
  • Caribou Biosciences, Inc. Net Income (Loss) Attributable to Parent for the quarter ending September 30, 2024 was -$34.7M, a 247% decline year-over-year.
  • Caribou Biosciences, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending September 30, 2024 was -$148M, a 56.7% decline year-over-year.
  • Caribou Biosciences, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$102M, a 2.66% decline from 2022.
  • Caribou Biosciences, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$99.4M, a 48.6% decline from 2021.
  • Caribou Biosciences, Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$66.9M, a 95.1% decline from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 -$148M -$34.7M -$24.7M -247% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-06
Q2 2024 -$123M -$37.7M -$8.18M -27.7% Apr 1, 2024 Jun 30, 2024 10-Q 2024-11-06
Q1 2024 -$115M -$41.2M -$13.2M -47% Jan 1, 2024 Mar 31, 2024 10-Q 2024-11-06
Q4 2023 -$102M -$34.5M -$7.52M -27.8% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-11
Q3 2023 -$94.6M -$10M +$16.6M +62.5% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-06
Q2 2023 -$111M -$29.5M -$2.82M -10.6% Apr 1, 2023 Jun 30, 2023 10-Q 2024-11-06
Q1 2023 -$108M -$28M -$8.96M -46.9% Jan 1, 2023 Mar 31, 2023 10-Q 2024-11-06
Q4 2022 -$99.4M -$27M -$8.51M -46.1% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-11
Q3 2022 -$90.9M -$26.6M -$5.67M -27% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-07
Q2 2022 -$85.2M -$26.7M -$12.4M -86.5% Apr 1, 2022 Jun 30, 2022 10-Q 2023-11-07
Q1 2022 -$72.9M -$19.1M -$5.93M -45.1% Jan 1, 2022 Mar 31, 2022 10-Q 2023-11-07
Q4 2021 -$66.9M -$18.5M -$3.78M -25.7% Oct 1, 2021 Dec 31, 2021 10-K 2022-03-21
Q3 2021 -$63.1M -$21M -$13M -164% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-08
Q2 2021 -$50.1M -$14.3M -$12.4M -664% Apr 1, 2021 Jun 30, 2021 10-Q 2022-11-08
Q1 2021 -$37.7M -$13.2M -$3.36M -34.3% Jan 1, 2021 Mar 31, 2021 10-Q 2022-11-08
Q4 2020 -$34.3M -$14.7M Oct 1, 2020 Dec 31, 2020 10-K 2022-03-21
Q3 2020 -$7.93M Jul 1, 2020 Sep 30, 2020 10-K 2022-03-21
Q2 2020 -$1.87M Apr 1, 2020 Jun 30, 2020 10-K 2022-03-21
Q1 2020 -$9.8M Jan 1, 2020 Mar 31, 2020 10-K 2022-03-21
* An asterisk sign (*) next to the value indicates that the value is likely invalid.